Home Companies Ambry Genetics

Ambry Genetics

Random
ArcherDX said its Archer Immunoverse and VariantPlex NGS assays will be used by Ambry toward offering its biopharma customers large-scale immune repertoire analysis and chimeric antigen T-cell receptor (CAR-T) manufacturing characterization and pharmacodynamics. [royaltystockphoto/Getty Images]
Ambry Genetics

ArcherDX, Ambry to Offer Immune Repertoire, CAR-T-Related Sequencing Services

Stephany Leigh Tandy-Connor
Ambry Genetics

Ambry Genetics Researchers Find False Positives in 40% of DTC Raw...

The Super Lab will employ expanded quality control measures
Ambry Genetics

Ambry Genetics “Super Lab” Opens

Ambry Genetics and My Gene Counsel said they will partner to offer medical-grade testing designed to confirm results of direct-to-consumer (DTC) genetic tests
Ambry Genetics

Ambry and My Gene Counsel Team Up on Tests to Confirm...

Konica Minolta envisions acquiring Ambry as the first step in its strategy of developing a leading presence in precision medicine. Upon close of the deal
Ambry Genetics

Konica Minolta to Acquire Ambry Genetics for Up to $1 Billion

New Products

View More
Load more
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up